May 31 AAV GTI First new-drug approval in a decade for ANCA-associated vasculitis tackles steroid-toxicity In October 2021, the US Food and Drug Administration issued its first new drug approval for antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in a decade. The first-in-class ... Read More